node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ABCC5 | SLC28A1 | ENSP00000333926 | ENSP00000286749 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1; Sodium-dependent and pyrimidine-selective. Exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). It also transports the antiviral pyrimidine nucleoside analogs 3’-azido-3’-deoxythymidine (AZT) and 2’,3’-dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). It has the following selective i [...] | 0.526 |
ABCC5 | SLC28A2 | ENSP00000333926 | ENSP00000315006 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2; Sodium-dependent and purine-selective transporter. Exhibits the transport characteristics of the nucleoside transport system cif or N1 subtype (N1/cif) (selective for purine nucleosides and uridine). Plays a critical role in specific uptake and salvage of purine nucleosides in kidney and other tissues | 0.428 |
ABCC5 | SLC28A3 | ENSP00000333926 | ENSP00000365413 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 3; Sodium-dependent, pyrimidine- and purine-selective. Involved in the homeostasis of endogenous nucleosides. Exhibits the transport characteristics of the nucleoside transport system cib or N3 subtype (N3/cib) (with marked transport of both thymidine and inosine). Employs a 2-1 sodium/nucleoside ratio. Also able to transport gemcitabine, 3’-azido-3’-deoxythymidine (AZT), ribavirin and 3-deazauridine | 0.457 |
ABCC5 | SLC29A2 | ENSP00000333926 | ENSP00000350024 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | solute carrier family 29 (nucleoside transporters), member 2; Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine | 0.656 |
ABCC5 | SLCO3A1 | ENSP00000333926 | ENSP00000320634 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | solute carrier organic anion transporter family, member 3A1; Mediates the Na(+)-independent transport of organic anions such as estrone-3-sulfate (PubMed-10873595). Mediates transport of prostaglandins (PG) E1 and E2, thyroxine (T4), deltorphin II, BQ-123 and vasopressin, but not DPDPE (a derivative of enkephalin lacking an N-terminal tyrosine residue), estrone-3- sulfate, taurocholate, digoxin nor DHEAS (PubMed-16971491) | 0.424 |
ABCC5 | SLCO4A1 | ENSP00000333926 | ENSP00000217159 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | solute carrier organic anion transporter family, member 4A1; Mediates the Na(+)-independent transport of organic anions such as the thyroid hormones T3 (triiodo-L-thyronine), T4 (thyroxine) and rT3, and of estrone-3-sulfate and taurocholate | 0.494 |
ABCC5 | UBC | ENSP00000333926 | ENSP00000344818 | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | ubiquitin C | 0.895 |
CD63 | SLC29A2 | ENSP00000257857 | ENSP00000350024 | CD63 molecule; This antigen is associated with early stages of melanoma tumor progression. May play a role in growth regulation | solute carrier family 29 (nucleoside transporters), member 2; Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine | 0.669 |
CD63 | UBC | ENSP00000257857 | ENSP00000344818 | CD63 molecule; This antigen is associated with early stages of melanoma tumor progression. May play a role in growth regulation | ubiquitin C | 0.909 |
MBNL1 | SLC29A2 | ENSP00000282486 | ENSP00000350024 | muscleblind-like splicing regulator 1; Mediates pre-mRNA alternative splicing regulation. Acts either as activator or repressor of splicing on specific pre-mRNA targets. Inhibits cardiac troponin-T (TNNT2) pre-mRNA exon inclusion but induces insulin receptor (IR) pre-mRNA exon inclusion in muscle. Antagonizes the alternative splicing activity pattern of CELF proteins. Regulates the TNNT2 exon 5 skipping through competition with U2AF2. Inhibits the formation of the spliceosome A complex on intron 4 of TNNT2 pre-mRNA. Binds to the stem-loop structure within the polypyrimidine tract of TN [...] | solute carrier family 29 (nucleoside transporters), member 2; Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine | 0.707 |
MBNL1 | UBC | ENSP00000282486 | ENSP00000344818 | muscleblind-like splicing regulator 1; Mediates pre-mRNA alternative splicing regulation. Acts either as activator or repressor of splicing on specific pre-mRNA targets. Inhibits cardiac troponin-T (TNNT2) pre-mRNA exon inclusion but induces insulin receptor (IR) pre-mRNA exon inclusion in muscle. Antagonizes the alternative splicing activity pattern of CELF proteins. Regulates the TNNT2 exon 5 skipping through competition with U2AF2. Inhibits the formation of the spliceosome A complex on intron 4 of TNNT2 pre-mRNA. Binds to the stem-loop structure within the polypyrimidine tract of TN [...] | ubiquitin C | 0.722 |
SLC28A1 | ABCC5 | ENSP00000286749 | ENSP00000333926 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1; Sodium-dependent and pyrimidine-selective. Exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). It also transports the antiviral pyrimidine nucleoside analogs 3’-azido-3’-deoxythymidine (AZT) and 2’,3’-dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). It has the following selective i [...] | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | 0.526 |
SLC28A1 | SLC29A2 | ENSP00000286749 | ENSP00000350024 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1; Sodium-dependent and pyrimidine-selective. Exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). It also transports the antiviral pyrimidine nucleoside analogs 3’-azido-3’-deoxythymidine (AZT) and 2’,3’-dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). It has the following selective i [...] | solute carrier family 29 (nucleoside transporters), member 2; Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine | 0.892 |
SLC28A1 | UPF2 | ENSP00000286749 | ENSP00000348708 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1; Sodium-dependent and pyrimidine-selective. Exhibits the transport characteristics of the nucleoside transport system cit or N2 subtype (N2/cit) (selective for pyrimidine nucleosides and adenosine). It also transports the antiviral pyrimidine nucleoside analogs 3’-azido-3’-deoxythymidine (AZT) and 2’,3’-dideoxycytidine (ddC). It may be involved in the intestinal absorption and renal handling of pyrimidine nucleoside analogs used to treat acquired immunodeficiency syndrome (AIDS). It has the following selective i [...] | UPF2 regulator of nonsense transcripts homolog (yeast) | 0.507 |
SLC28A2 | ABCC5 | ENSP00000315006 | ENSP00000333926 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2; Sodium-dependent and purine-selective transporter. Exhibits the transport characteristics of the nucleoside transport system cif or N1 subtype (N1/cif) (selective for purine nucleosides and uridine). Plays a critical role in specific uptake and salvage of purine nucleosides in kidney and other tissues | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | 0.428 |
SLC28A2 | SLC29A2 | ENSP00000315006 | ENSP00000350024 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2; Sodium-dependent and purine-selective transporter. Exhibits the transport characteristics of the nucleoside transport system cif or N1 subtype (N1/cif) (selective for purine nucleosides and uridine). Plays a critical role in specific uptake and salvage of purine nucleosides in kidney and other tissues | solute carrier family 29 (nucleoside transporters), member 2; Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine | 0.897 |
SLC28A2 | UPF2 | ENSP00000315006 | ENSP00000348708 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2; Sodium-dependent and purine-selective transporter. Exhibits the transport characteristics of the nucleoside transport system cif or N1 subtype (N1/cif) (selective for purine nucleosides and uridine). Plays a critical role in specific uptake and salvage of purine nucleosides in kidney and other tissues | UPF2 regulator of nonsense transcripts homolog (yeast) | 0.570 |
SLC28A3 | ABCC5 | ENSP00000365413 | ENSP00000333926 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 3; Sodium-dependent, pyrimidine- and purine-selective. Involved in the homeostasis of endogenous nucleosides. Exhibits the transport characteristics of the nucleoside transport system cib or N3 subtype (N3/cib) (with marked transport of both thymidine and inosine). Employs a 2-1 sodium/nucleoside ratio. Also able to transport gemcitabine, 3’-azido-3’-deoxythymidine (AZT), ribavirin and 3-deazauridine | ATP-binding cassette, sub-family C (CFTR/MRP), member 5 | 0.457 |
SLC28A3 | SLC29A2 | ENSP00000365413 | ENSP00000350024 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 3; Sodium-dependent, pyrimidine- and purine-selective. Involved in the homeostasis of endogenous nucleosides. Exhibits the transport characteristics of the nucleoside transport system cib or N3 subtype (N3/cib) (with marked transport of both thymidine and inosine). Employs a 2-1 sodium/nucleoside ratio. Also able to transport gemcitabine, 3’-azido-3’-deoxythymidine (AZT), ribavirin and 3-deazauridine | solute carrier family 29 (nucleoside transporters), member 2; Mediates equilibrative transport of purine, pyrimidine nucleosides and the purine base hypoxanthine. Very less sensitive than SLC29A1 to inhibition by nitrobenzylthioinosine (NBMPR), dipyridamole, dilazep and draflazine | 0.895 |
SLC28A3 | SLCO3A1 | ENSP00000365413 | ENSP00000320634 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 3; Sodium-dependent, pyrimidine- and purine-selective. Involved in the homeostasis of endogenous nucleosides. Exhibits the transport characteristics of the nucleoside transport system cib or N3 subtype (N3/cib) (with marked transport of both thymidine and inosine). Employs a 2-1 sodium/nucleoside ratio. Also able to transport gemcitabine, 3’-azido-3’-deoxythymidine (AZT), ribavirin and 3-deazauridine | solute carrier organic anion transporter family, member 3A1; Mediates the Na(+)-independent transport of organic anions such as estrone-3-sulfate (PubMed-10873595). Mediates transport of prostaglandins (PG) E1 and E2, thyroxine (T4), deltorphin II, BQ-123 and vasopressin, but not DPDPE (a derivative of enkephalin lacking an N-terminal tyrosine residue), estrone-3- sulfate, taurocholate, digoxin nor DHEAS (PubMed-16971491) | 0.415 |